Immuneering Corporation (IMRX) Revenue 2020–2023
Immuneering Corporation (IMRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2023 · since FY2020: $2.3M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $316,952 | -84.8% |
| FY2021 | $2.1M | -10.0% |
| FY2020 | $2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IMRX financial trends
IMRX Net incomeIMRX Net marginIMRX Gross profitIMRX Gross marginIMRX Operating incomeIMRX Operating marginIMRX Operating cash flowIMRX Free cash flowIMRX Capital expendituresIMRX Return on equityIMRX Stock buybacksIMRX Dividends paidIMRX Total assetsIMRX Total liabilitiesIMRX Shareholders’ equityIMRX overview →